Alan S. Roemer

Alan S. Roemer serves as the Chairman of the Board of Directors at IN8bio and UTILITY Therapeutics, focusing on innovative therapies for cancer and urinary tract infections, respectively. Roemer is also a member of the Board of Directors for bit.bio and NexImmune, Inc., where contributions include overseeing audit and financial committees. Additional roles include serving on the Board of Trustees as Treasurer for Helene Fuld College of Nursing and as a Senior Advisor for Biolojic Design, Ltd., with a focus on AI-driven therapeutic antibodies. Previous experience includes founding leadership positions at Roivant Sciences and board involvement at SomPharmaceuticals and Envisagenics. Academic credentials include a Bachelor of Science in Business Administration from Georgetown University and an MBA and MPH from Emory University.